(2S,3R,4R,5R,6R)-2-(1-(2-Bromo-5-chlorophenyl)-3-methyl-1H-1,2,4-triazol-5-yl)-6-(hydroxymethyl)-4-(4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl)oxane-3,5-diol

ID: ALA5193419

Chembl Id: CHEMBL5193419

PubChem CID: 138577215

Max Phase: Preclinical

Molecular Formula: C23H19BrClF3N6O4

Molecular Weight: 615.79

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc([C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cc(F)c(F)c(F)c4)nn3)[C@H]2O)n(-c2cc(Cl)ccc2Br)n1

Standard InChI:  InChI=1S/C23H19BrClF3N6O4/c1-9-29-23(34(31-9)16-6-11(25)2-3-12(16)24)22-21(37)19(20(36)17(8-35)38-22)33-7-15(30-32-33)10-4-13(26)18(28)14(27)5-10/h2-7,17,19-22,35-37H,8H2,1H3/t17-,19+,20+,21-,22-/m1/s1

Standard InChI Key:  MPRHMKQUQKTGTI-WHCFWRGISA-N

Alternative Forms

  1. Parent:

    ALA5193419

    ---

Associated Targets(Human)

LGALS3 Tchem Galectin-3 (545 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lgals3 Galectin-3 (98 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 615.79Molecular Weight (Monoisotopic): 614.0292AlogP: 3.06#Rotatable Bonds: 5
Polar Surface Area: 131.34Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.85CX Basic pKa: 0.28CX LogP: 3.44CX LogD: 3.44
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -0.83

References

1. Liu C, Jalagam PR, Feng J, Wang W, Raja T, Sura MR, Manepalli RKVLP, Aliphedi BR, Medavarapu S, Nair SK, Muthalagu V, Natesan R, Gupta A, Beno B, Panda M, Ghosh K, Shukla JK, Sale H, Haldar P, Kalidindi N, Shah D, Patel D, Mathur A, Ellsworth BA, Cheng D, Regueiro-Ren A..  (2022)  Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3.,  65  (16.0): [PMID:35969688] [10.1021/acs.jmedchem.2c00517]

Source